IFM Investors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.3M Buy
84,397
+9,772
+13% +$4.69M 0.28% 64
2026
Q1
$36.7M Buy
74,625
+2,071
+3% +$1.12M 0.31% 61
2025
Q4
$42M Buy
72,554
+505
+0.7% +$286K 0.35% 45
2025
Q3
$33.4M Sell
72,049
-446
-0.6% -$208K 0.29% 60
2025
Q2
$29.4M Buy
72,495
+2,976
+4% +$1.24M 0.28% 66
2025
Q1
$34.6M Sell
69,519
-315
-0.5% -$171K 0.37% 44
2024
Q4
$36.3M Sell
69,834
-6,613
-9% -$3.64M 0.37% 44
2024
Q3
$47.3M Sell
76,447
-746
-1% -$442K 0.45% 34
2024
Q2
$42.7M Sell
77,193
-230
-0.3% -$132K 0.43% 36
2024
Q1
$45M Buy
77,423
+116
+0.2% +$65.1K 0.49% 32
2023
Q4
$41M Sell
77,307
-687
-0.9% -$333K 0.5% 35
2023
Q3
$39.5M Buy
77,994
+2,677
+4% +$1.43M 0.52% 31
2023
Q2
$39.3M Buy
75,317
+3,018
+4% +$1.63M 0.51% 35
2023
Q1
$41.7M Buy
72,299
+2,336
+3% +$1.32M 0.63% 26
2022
Q4
$38.5M Buy
69,963
+3,832
+6% +$2.03M 0.65% 27
2022
Q3
$33.5M Buy
66,131
+733
+1% +$410K 0.61% 29
2022
Q2
$35.5M Buy
65,398
+3,882
+6% +$2.14M 0.62% 30
2022
Q1
$36.3M Buy
61,516
+10,164
+20% +$5.84M 0.56% 31
2021
Q4
$34.3M Sell
51,352
-714
-1% -$446K 0.63% 24
2021
Q3
$29.7M Buy
52,066
+12
+0% +$6.59K 0.62% 26
2021
Q2
$26.3M Buy
52,054
+9,395
+22% +$4.43M 0.54% 36
2021
Q1
$19.5M Buy
42,659
+4,440
+12% +$2.12M 0.52% 38
2020
Q4
$17.8M Buy
38,219
+5,223
+16% +$2.45M 0.57% 35
2020
Q3
$14.6M Buy
32,996
+3,630
+12% +$1.5M 0.61% 33
2020
Q2
$10.6M Sell
29,366
-12,243
-29% -$4.1M 0.55% 37
2020
Q1
$11.9M Sell
41,609
-1,251
-3% -$394K 0.53% 41
2019
Q4
$13.9M Sell
42,860
-59
-0.1% -$17.9K 0.49% 40
2019
Q3
$12.5M Buy
42,919
+14,813
+53% +$4.24M 0.46% 44
2019
Q2
$8.25M Buy
28,106
+2,297
+9% +$633K 0.47% 41
2019
Q1
$7.06M Buy
25,809
+2,486
+11% +$619K 0.45% 48
2018
Q4
$5.22M Buy
23,323
+2,149
+10% +$504K 0.42% 50
2018
Q3
$5.17M Buy
21,174
+3,054
+17% +$703K 0.39% 57
2018
Q2
$3.75M Buy
18,120
+5,691
+46% +$1.21M 0.35% 59
2018
Q1
$2.57M Buy
12,429
+1,267
+11% +$266K 0.37% 58
2017
Q4
$2.12M Buy
11,162
+218
+2% +$41.8K 0.33% 64
2017
Q3
$2.07M Buy
10,944
+275
+3% +$49.8K 0.35% 62
2017
Q2
$1.86M Buy
10,669
+2,659
+33% +$447K 0.33% 67
2017
Q1
$1.23M Buy
8,010
+3,020
+61% +$462K 0.31% 73
2016
Q4
$704K Buy
+4,990
New +$736K 0.33% 77

Other funds holding TMO

IFM Investors's TMO Position: Q2 2026 in Review

IFM Investors increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $4.69M and bringing the position to 84,397 shares worth $42.3M. The position accounts for 0.28% of the portfolio, ranked #64.

IFM Investors first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $47.3M in Q3 2024. 770 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • IFM Investors held 84,397 shares of Thermo Fisher Scientific worth $42.3M as of Q2 2026.
  • IFM Investors bought 9,772 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.69M.
  • Thermo Fisher Scientific made up 0.28% of IFM Investors's portfolio in Q2 2026, its #64 holding.
  • IFM Investors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's Thermo Fisher Scientific position peaked at $47.3M in Q3 2024.
  • 770 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.